The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for the fiscal year (FY) 2023 Medication-Assisted Treatment – Prescription Drug and Opioid Addiction (Short Title: MAT-PDOA) program.
Donor Name: Substance Abuse and Mental Health Services Administration (SAMHSA)
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 03/07/2023
Size of the Grant: $500,000
Grant Duration: 1-5 years
Details:
The purpose of this program is to provide resources to help expand and enhance access to Medications for Opioid Use Disorder (MOUD). It is expected that this program will help to increase access to MOUD for individuals with Opioid Use Disorder (OUD), including individuals from diverse racial, ethnic, sexual and gender minority communities; and decrease illicit opioid use and prescription opioid misuse.
Award recipients will be expected to provide FDA-approved MOUD in an ongoing manner. MOUD is to be provided in combination with comprehensive psychosocial services, including counseling, behavioral therapies, recovery support services (RSS), and other clinically appropriate services, based on individual need and shared decision-making.
Funding Information
Estimated Total Available Funding: Up to $18,200,000 (including $9.5 million for tribes/tribal organizations).
Project Period
Up to 5 years
Allowable Activities
Allowable activities are an allowable use of funds but are not required. Allowable activities may include:
- Implement mobile and/or non-mobile medication units that provide appropriate privacy and adequate space to administer and dispense medications for OUD treatment in accordance with federal regulations2 . (Note: Use of funds for the purchase and/or maintenance of mobile units, safes for non-mobile medication units, and/or any related equipment falls within the 15 percent limit on program infrastructure development referenced above.) The following services, which are not subject to the 15% limit detailed above, may be provided in mobile medication units, assuming compliance with all applicable federal, state, and local law:
- Administering and dispensing medications for OUD treatment (with required licensure and certifications)
- Prescribing of buprenorphine by waivered practitioners
- Collecting samples for drug testing or analysis
- Dispensing of take-home medications (OTPs only)
- In units that provide appropriate privacy and adequate space, intake/initial psychosocial and appropriate medical assessments (with a full physical examination to be completed or provided within 14-days of admission);
- Initiating methadone (OTPs only) or buprenorphine (OTPs or waivered practitioners) after an appropriate medical assessment has been performed.
- In units that provide appropriate privacy and have adequate space, other services, such as counseling, may be provided directly or when permissible through use of telehealth services
- Non-mobile medication units may also offer the above services where space allows for quality patient care and as consistent with state and local laws and regulations.
- Implement evidence-based contingency management programs to treat cooccurring stimulant use disorder to improve retention in care.
- Develop and implement tobacco cessation programs, activities, and/or strategies for people with OUD who are receiving MOUD, to include diverse racial and ethnic minority groups.
- Conduct outreach and screening to identify incarcerated individuals who are within four months from release and may benefit from MOUD services upon release from a jail or detention facility. Funds may be used to provide MOUD to incarcerated individuals within four months of release to communities.
- Provide education, screening, including screening and confirmatory laboratory testing, care coordination, risk reduction interventions, and counseling for HIV, hepatitis C, and other infectious diseases for people with OUD who are receiving MOUD.
- Provide recovery housing for individuals actively engaged in MOUD and other psychosocial services. Recipients must ensure that recovery housing supported under this award is in an appropriate and legitimate facility. Recipients must describe the mechanism(s) in place in their jurisdictions to assure that a recovery housing facility to receive these funds supports, and provides clients access to, evidence-based treatment, including all forms of MOUD, in a safe and appropriate setting.
- Provide dental kits to promote oral health for individuals with OUD enrolled in treatment with buprenorphine (i.e., dental kits are limited to items such as toothpaste, toothbrush, dental floss, non-alcohol containing mouthwash, and educational information related to accessing dental care).
- Develop and implement a low threshold MOUD approach that offers services and makes minimal requirements of patients, thus removing or reducing barriers to treatment and expanding access to care.
- Recipients may use up to $25,000 per year to provide transportation for clients in rural areas and for unemployed clients with verification.
- Assess for and respond to the needs of individuals and families served by the program who are at risk for or experiencing homelessness. This could include an assessment of homelessness risk, housing status, and eligibility for federal housing programs, and collaboration with homeless services organizations and housing providers, including referral partnerships with public housing agencies and coordination with local homeless Coordinated Entry systems.
Eligibility Criteria
Eligible applicants are States, political subdivisions of States, Indian tribes, or tribal organizations (as such terms are defined in section 4 of the Indian Self-Determination and Education Assistance Act), health facilities, or programs operated by or in accordance with a contract or grant with the Indian Health Service, or other public or non-profit private entities.
Tribal organization means the recognized body of any AI/AN tribe; any legally established organization of AI/ANs which is controlled, sanctioned, or chartered by such governing body, or which is democratically elected by the adult members of the Indian community to be served by such organization and which includes the maximum participation of AI/ANs in all phases of its activities. Consortia of tribes or tribal organizations are eligible to apply, but each participating entity must indicate its approval. A single tribe in the consortium must be the legal applicant, the recipient of the award, and the entity legally responsible for satisfying the award requirements.
Urban Indian Organization (UIO) (as identified by the Indian Health Service Office of Urban Indian Health Programs through active Title V awards/contracts) means a nonprofit corporate body situated in an urban center governed by an urban Indian-controlled board of directors, and providing for the maximum participation of all interested Individuals and groups, which body is capable of legally cooperating with other public and private entities for the purpose of performing the activities described in 503(a) of 25 U .S.C. § 1603. UIOs are not tribes or tribal governments and do not have the same consultation rights or trust relationship with the federal government. MAT-PDOA recipients who received funding in FY2021 under TI-21-006 or in FY2022 under TI-22-013 are not eligible to apply for this funding opportunity.
For more information, visit Grants.gov.
